p53 is frequently mutated in Barrett's metaplasia of the intestinal type

被引:0
|
作者
Campomenosi, P
Conio, M
Bogliolo, M
Urbini, S
Assereto, P
Aprile, A
Monti, P
Aste, H
Lapertosa, G
Inga, A
Abbondandolo, A
Fronza, G
机构
[1] IST NAZL RIC CANC,CTR STUDY TUMORS,ENVIRONM ORIGINS MUTAGENESIS LAB,I-16132 GENOA,ITALY
[2] IST NAZL RIC CANC,GASTROENTEROL UNIT,I-16132 GENOA,ITALY
[3] UNIV GENOA,CHAIR ANAT PATHOL,GENOA,ITALY
[4] UNIV GENOA,CHAIR GENET,GENOA,ITALY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Barrett's Esophagus (BE) is a complication of gastroesophageal reflux in which the normal squamous epithelium of the lower esophagus is replaced by metaplastic tissue. The clinical significance of this condition is the associated predisposition to adenocarcinomas (ADCs). Three types of BE have been characterized: the gastric fundic (F) type, the gastric cardial (C) type, and the intestinal (I) type. The latter is the most closely associated with the development of ADCs; the causes of this bias remain unknown. To determine whether p53 and/or K-ms gene alterations (a) are present in preneoplastic lesions and (b) are associated with a specific histotype, we performed PCR-based denaturing gradient gel electrophoresis (DGGE) analysis of exon 1 (codons 12-13) of K-ms gene and of exons 5-8 of the p53 gene in biopsies obtained from 30 patients with BE of the I type (9 patients), combined I type (I + C +/- F; 10 patients) and non-I type (C, F, or C + F; 11 patients). None of the cases under study revealed K-ras mutations, whereas biopsies from 12 patients showed at least one p53 DGGE variant. Four patients showed the exact same variants in leukocytes also (polymorphisms), whereas eight cases revealed specific DGGE variants only in biopsies. The molecular characterization of these variants revealed that four of them showed a single base pair substitution, and four showed multiple mutations. Of 17 somatic mutations, all but 1 were base pair substitutions located mainly in exons 7 and 8. The majority of these mutations were GC targeted (13 of 16; 81%), 54% (7 of 13) of which were transitions occurring at CpG sites. All somatic mutations were found in BE with at least one I component. The association with the histotype was statistically significant (P < 0.03; pure I type versus non-I type; P < 0.04, combined I type versus non-I type; Fisher's exact test). Loss of heterozygosity in the vicinity of the p53 locus was evaluated by PCR using a highly polymorphic variable number of tandem repeats marker on 25 out of 30 cases. Ninety-two % of the cases analyzed were informative, and none of them showed LOH. In conclusion, we showed that p53 mutations are frequently observed in specimens from BE patients of the I-type, whereas no involvement of K-ras (exon 1) mutational activation was observed. In light of the key roles that the p53 protein plays in controlling cell cycle and cell diploidy, this result may suggest why this type of metaplasia is the most closely associated to the development of ADCs.
引用
收藏
页码:559 / 565
页数:7
相关论文
共 50 条
  • [31] Expression of ARID1A and p53 in Patients With a Consensus Diagnosis of Barrett's Foveolar and Intestinal-Type Dysplasia
    Willis, Eric
    Wiland, Homer
    Allende, Daniela
    Cruise, Michael
    Goldblum, John
    Liu, Xiuli
    Pai, Rish
    Plesec, Thomas
    Yerian, Lisa
    Carver, Paula
    Patil, Deepa
    LABORATORY INVESTIGATION, 2015, 95 : 198A - 199A
  • [32] Expression of ARID1A and p53 in Patients With a Consensus Diagnosis of Barrett's Foveolar and Intestinal-Type Dysplasia
    Willis, Eric
    Wiland, Homer
    Allende, Daniela
    Cruise, Michael
    Goldblum, John
    Liu, Xiuli
    Pai, Rish
    Plesec, Thomas
    Yerian, Lisa
    Carver, Paula
    Patil, Deepa
    MODERN PATHOLOGY, 2015, 28 : 198A - 199A
  • [33] Prognostic significance of p53 immunohistochemistry for p53 mutated tumors
    Wurl, P
    Dralle, H
    Taubert, H
    Meye, A
    Berger, D
    Schmidt, H
    Holzhausen, HJ
    Rath, FW
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 333 - 333
  • [34] Polymorphisms of Exon 4 of P53 gene in gastric intestinal metaplasia in Hungary
    Szoke, Dominika
    Molnar, Bela
    Tulassay, Zsolt
    GASTROENTEROLOGY, 2006, 130 (04) : A391 - A391
  • [35] Detection of intestinal metaplasia in Barrett's esophagus
    Harrison, Rebecca
    Perry, Ian
    Haddadin, William
    McDonald, Stuart
    Bryan, Richard
    Abrams, Keith
    Sampliner, Richard
    Talley, Nicholas J.
    Moayyedi, Paul
    Jankowski, Janusz A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (10): : 2353 - 2354
  • [36] Chromoscopy of intestinal metaplasia in Barrett's esophagus
    Canto, MI
    Yoshida, T
    Gossner, L
    ENDOSCOPY, 2002, 34 (04) : 330 - 336
  • [37] Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53
    Laurence Odin
    Marie Favrot
    Dominique Poujol
    Jean-Philippe Michot
    Philippe Moingeon
    James Tartaglia
    Isabelle Puisieux
    Cancer Gene Therapy, 2001, 8 : 87 - 98
  • [38] Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells
    Peter Buttgereit
    Frank Schakowski
    Angela Märten
    Karsten Brand
    Sabine Renoth
    Carsten Ziske
    Björn Schöttker
    Oliver Ebert
    Roland Schroers
    Ingo GH Schmidt-Wolf
    Cancer Gene Therapy, 2001, 8 : 430 - 439
  • [39] Canarypox virus expressing wild type p53 for gene therapy in murine tumors mutated in p53
    Odin, L
    Favrot, M
    Poujol, D
    Michot, JP
    Moingeon, P
    Tartaglia, J
    Puisieux, I
    CANCER GENE THERAPY, 2001, 8 (02) : 87 - 98
  • [40] p53 mutation biases SCJ progenitor cells towards dysplasia rather than metaplasia in Barrett's esophagus
    Lian, Guodong
    Malagola, Ermanno
    Zhao, Junfei
    Friedman, Richard A.
    Zamechek, Leah B.
    Wang, Timothy C.
    CANCER RESEARCH, 2023, 83 (07)